The fact that Swedish individuals with AUD who took semaglutide had fewer hospitalizations than those on, say, naltrexone, might simply be because naltrexone is given to people with significantly worse pathology or that those with access to GLP-1 drugs also have access to avenues of care for AUD outside of the hospital system
Sara presented this analysis at the AMCP Annual Meeting 2026, helping bring real-world insights into conversations shaping the future of managed care, and were proud to share it as part of our Ventegra Insights series
Proper handling preserves peptide integrity and ensures consistent research outcomes across experiments
Effect of Buformin and Diphenylhydantoin on the Life Span, Estrous Function and Spontaneous Tumor Incidence in Rats
are highly exposed to environmental pollutants
Most affordable Compounded GLP-1 $90 / 4-week supply* Same price for all refills and doses